Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 111796175 | 11179617 | 5 | F | 20150326 | 20160916 | 20150611 | 20160926 | EXP | JP-ALEXION PHARMACEUTICALS INC.-A201502102 | ALEXION | 33.00 | YR | F | Y | 49.00000 | KG | 20160926 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 111796175 | 11179617 | 1 | PS | SOLIRIS | ECULIZUMAB | 1 | Intravenous (not otherwise specified) | 900 MG, QW | 16800 | MG | Y | 125166 | 900 | MG | CONCENTRATE FOR SOLUTION FOR INFUSION | /wk | |||
| 111796175 | 11179617 | 2 | SS | SOLIRIS | ECULIZUMAB | 1 | Intravenous (not otherwise specified) | 1200 MG, Q2W | 16800 | MG | Y | 125166 | 1200 | MG | CONCENTRATE FOR SOLUTION FOR INFUSION | QOW | |||
| 111796175 | 11179617 | 3 | SS | SOLIRIS | ECULIZUMAB | 1 | Intravenous (not otherwise specified) | 1200 MG, Q3W OR Q4W | 16800 | MG | Y | AC6839D01 | 125166 | 1200 | MG | CONCENTRATE FOR SOLUTION FOR INFUSION | |||
| 111796175 | 11179617 | 4 | C | MICARDIS | TELMISARTAN | 1 | Oral | 20 MG, QD | 2680 | MG | 0 | 20 | MG | QD | |||||
| 111796175 | 11179617 | 5 | C | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | 2.5 MG, QD | 0 | 2.5 | MG | QD | |||||||
| 111796175 | 11179617 | 6 | C | BAYASPIRIN | ASPIRIN | 1 | Oral | 100 MG, QD | 0 | 100 | MG | QD | |||||||
| 111796175 | 11179617 | 7 | C | PREDONINE | PREDNISOLONEPREDNISOLONE ACETATEPREDNISOLONE SODIUM SUCCINATE | 1 | Oral | 50 MG, QD | 12500 | MG | 0 | 50 | MG | QD | |||||
| 111796175 | 11179617 | 8 | C | PREDONINE | PREDNISOLONEPREDNISOLONE ACETATEPREDNISOLONE SODIUM SUCCINATE | 1 | Oral | 12.5 MG, QD | 12500 | MG | 0 | 12.5 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 111796175 | 11179617 | 1 | Haemolytic uraemic syndrome |
| 111796175 | 11179617 | 4 | Prophylaxis |
| 111796175 | 11179617 | 5 | Prophylaxis |
| 111796175 | 11179617 | 6 | Thrombosis prophylaxis |
| 111796175 | 11179617 | 7 | Systemic lupus erythematosus |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 111796175 | 11179617 | HO |
| 111796175 | 11179617 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 111796175 | 11179617 | Inappropriate schedule of drug administration | |
| 111796175 | 11179617 | Pneumonia | |
| 111796175 | 11179617 | Staphylococcal infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 111796175 | 11179617 | 1 | 20140918 | 20141009 | 0 | |
| 111796175 | 11179617 | 2 | 20141016 | 20150312 | 0 | |
| 111796175 | 11179617 | 3 | 20150326 | 20150604 | 0 | |
| 111796175 | 11179617 | 4 | 20141125 | 20150616 | 0 | |
| 111796175 | 11179617 | 5 | 20141106 | 0 | ||
| 111796175 | 11179617 | 6 | 20141120 | 0 | ||
| 111796175 | 11179617 | 7 | 20140801 | 20150613 | 0 | |
| 111796175 | 11179617 | 8 | 20150614 | 0 |